Cantor Fitzgerald Reaffirms Overweight Rating for Cabaletta Bio (NASDAQ:CABA)

Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $50.00 target price on the stock. Several other research analysts have also recently issued reports on the company. Wells Fargo & Company increased their price objective on […]

Related Keywords

Gwendolyn Binder ,Jefferies Financial Group ,Cabaletta Bio Company Profile ,Wells Fargo Company ,Macroview Investment Management ,Cantor Fitzgerald ,Cabaletta Bio Inc ,Comerica Bank ,Nasdaq ,Citigroup ,Ameritas Investment Partners Inc ,Tower Research Capital ,Cabaletta Bio ,Free Report ,Financial Group ,Research Capital ,Investment Management ,Ameritas Investment Partners ,Get Free Report ,Cabaletta Bio Daily ,